This document includes general, academic, and educational materials on HIV criminalization in the United States, as well as emerging issues related to the intersection of data confidentiality and ethics with HIV criminal exposure laws. “HIV criminalization” broadly refers to state HIV criminal exposure laws which criminalize the behavior of people with HIV with the stated goal of discouraging and punishing conduct that can lead to transmission.
With roughly two million cases in the U.S., trichomoniasis (“trich”) is the most common STI you’ve never heard of. Most cases don’t have obvious symptoms but undetected trich can make it more like to contract or transmit other STIs (like HIV) and the infection is linked to pre-term delivery and low-birth weight babies. Learn more about Trichomoniasis on this webpage.
The resources presented here are based on data obtained from the Hepatitis B Foundation patient engagement survey in 2020. The survey was an anonymous and online and was offered globally for individuals living with chronic hepatitis B (CHB) and aged 18 years old and older. It received 1,707 responses from people living in 100 countries around the globe.
Harm Reduction Hacks is the product of a series of 38 qualitative conversations with harm reduction leaders representing every region of the US that took place in the Fall of 2020 and the Spring of 2021.
New data from UNAIDS on the global HIV response reveals that during the last two years of COVID-19 and other global crises, progress against the HIV pandemic has faltered, resources have shrunk, and millions of lives are at risk as a result. The new report, In Danger, was launched ahead of the International AIDS Conference in Montreal, Canada.
An end to AIDS in children, achieved through a strong, strategic, and action-oriented alliance of multisectoral stakeholders at national, regional, and global levels that works with women children and adolescents living with HIV, national governments, and partners to mobilize leadership, funding, and action to end AIDS in children by 2030.
This research discusses how PrEP was approved for HIV prevention in the US in 2012; uptake has been slow. Black and Hispanic people have higher rates of new HIV diagnoses than White non-Hispanic people in the US. We describe the inequitable use of PrEP by race within US regions from 2012-2021.
HIVMA created this document as a reference for HIV clinicians and educators across the trainee and provider continuum to help improve the delivery of HIV care and prevention. The resources include guidelines, clinical decision-making tools, continuing education opportunities, provider directories and other resources. Click on the links below for quick access to a section of interest.
This page offers considerations for the care of people with HIV, including prevention and treatment of monkeypox.
In 2019, NASTAD launched HepTAC, an online technical assistance (TA) and capacity building center for health department hepatitis programs. The primary goal of HepTAC is to build state and local technical expertise and enhance health department capacity to eliminate viral hepatitis. Direct technical assistance is provided primarily via the online platform using video conference technology to connect NASTAD Hepatitis team staff and its consultants to health department hepatitis staff across the county.
